Umang Swami: Patient-level analysis of ph3 SWOG 1216 trial in mHSPC
Umang Swami, Assistant Professor in the Division of Oncology at the Huntsman Cancer Institute, shared on X:
“Just in European Urology Oncology
In patient-level analysis of ph3 SWOG 1216 trial in mHSPC Prostate Cancer. Higher BMI associated with high OS. Helpful data for patient counseling/prognostication.”
Shilpa Gupta, Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic, shared this post on X, adding:
“Huge congrats Umang Swami, Neeraj Agarwal on leading this important work demonstrating association of higher BMI and better OS in SWOG S1216 trial in mHSPC.”
Authors: Umang Swami, Yeonjung Jo, Arshit Narang, Melissa Plets, Chadi Hage Chehade, Georges Gebrael, Shilpa Gupta, Zin Myint, Catherine Tangen, Primo N. Lara Jr., Ian M. Thompson Jr., Maha H.A. Hussain, Tanya B. Dorff, Seth P. Lerner, Neeraj Agarwal
Umang Swami is an Assistant Professor in the Division of Oncology at the Huntsman Cancer Institute, University of Utah, specializing in medical oncology with a focus on genitourinary cancers. He earned his medical degree from Sawai Man Singh Medical College in India and gained research experience as a Visiting Scientist at the Montefiore-Einstein Cancer Center in New York, where he worked on phase I studies for advanced solid tumors.
Dr. Shilpa Gupta is the Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023